Litcius/Paper detail

Dasatinib in combination with BMS-754807 induce synergistic cytotoxicity in lung cancer cells through inhibiting lung cancer cell growth, and inducing autophagy as well as cell cycle arrest at the G1 phase

Chan Zhang, Xinan Zhao, Zifeng Wang, Tao Gong, Hong Zhao, Dong Zhang, Yuhu Niu, Xiaoning Li, Xuhua Zhao, Gaopeng Li, Xiushan Dong, Li Zhang, Chang Liu, Jun Xu, Baofeng Yu

2023Investigational New Drugs24 citationsDOI

Topics & Concepts

DasatinibCancer researchAutophagyTyrosine kinaseCancerCell cyclePI3K/AKT/mTOR pathwayLung cancerCell growthDownregulation and upregulationMedicineBiologySignal transductionCell biologyInternal medicineApoptosisBiochemistryGenePI3K/AKT/mTOR signaling in cancerChronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia Treatments
Dasatinib in combination with BMS-754807 induce synergistic cytotoxicity in lung cancer cells through inhibiting lung cancer cell growth, and inducing autophagy as well as cell cycle arrest at the G1 phase | Litcius